Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » Utilizing microbial metabolites: new avenues in food technology for health care
Featured Health

Utilizing microbial metabolites: new avenues in food technology for health care

Paul E.By Paul E.October 2, 2024No Comments4 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


The gastrointestinal tract is a complex microbiome environment that significantly influences human health through the production of various microbial metabolites. These small molecule byproducts are important in regulating important body functions such as metabolism and immune responses, and influence overall health. Current research focuses on the gut microbiome as a fundamental aspect of health and proposes a gut health index as a universal indicator based on microbial diversity. Despite advances, many questions remain regarding how these metabolites directly influence physiological and pathological processes.

This research topic aims to explore how microbial metabolites influence host health, particularly their direct role in the development and progression of gastrointestinal and metabolic conditions. The aim is to comprehensively characterize microbial metabolites, decipher their biochemical pathways and interactions with host metabolic byproducts, and explore their therapeutic potential. This integrated approach aims to manage gastrointestinal and metabolic health through the regulation of these metabolites. We are seeking contributions on the following specific themes:

• Utilize state-of-the-art techniques such as metagenomics and mass spectrometry to accurately identify metabolites.
• Investigate how these metabolites affect cellular functions such as signal transduction pathways and gene regulation.
• Analyze differences in metabolite levels between healthy individuals and people with certain digestive or metabolic disorders
• Evaluation of the effects of metabolites on diseases such as IBD, IBS, and colorectal cancer.
• Exploring the relationship between metabolites and diseases such as obesity, diabetes, and MASLD.
• Innovate new treatments targeting diet and the microbiome.

Through this focused exploration, we welcome contributions that can be integrated into precision medicine tailored to individual gut microbiome profiles and revolutionize the understanding and treatment of complex diseases.

Keywords: diet, microbiome, gastroenterology, metabolism, inflammatory bowel disease, microbial metabolites, precision nutrition

Important note: All submissions to this research topic must be within the scope of the section and journal to which they are submitted, as defined in the mission statement. Frontiers reserves the right to direct out-of-scope manuscripts to a more appropriate section or journal at any stage of peer review.

The gastrointestinal tract is a complex microbiome environment that significantly influences human health through the production of various microbial metabolites. These small molecule byproducts are important in regulating important body functions such as metabolism and immune responses, and influence overall health. Current research focuses on the gut microbiome as a fundamental aspect of health and proposes a gut health index as a universal indicator based on microbial diversity. Despite advances, many questions remain regarding how these metabolites directly influence physiological and pathological processes.

This research topic aims to explore how microbial metabolites influence host health, particularly their direct role in the development and progression of gastrointestinal and metabolic conditions. The aim is to comprehensively characterize microbial metabolites, decipher their biochemical pathways and interactions with host metabolic byproducts, and explore their therapeutic potential. This integrated approach aims to manage gastrointestinal and metabolic health through the regulation of these metabolites. We are seeking contributions on the following specific themes:

• Utilize state-of-the-art techniques such as metagenomics and mass spectrometry to accurately identify metabolites.
• Investigate how these metabolites affect cellular functions such as signal transduction pathways and gene regulation.
• Analyze differences in metabolite levels between healthy individuals and people with certain digestive or metabolic disorders
• Evaluation of the effects of metabolites on diseases such as IBD, IBS, and colorectal cancer.
• Exploring the relationship between metabolites and diseases such as obesity, diabetes, and MASLD.
• Innovate new treatments targeting diet and the microbiome.

Through this focused exploration, we welcome contributions that can be integrated into precision medicine tailored to individual gut microbiome profiles and revolutionize the understanding and treatment of complex diseases.

Keywords: diet, microbiome, gastroenterology, metabolism, inflammatory bowel disease, microbial metabolites, precision nutrition

Important note: All submissions to this research topic must be within the scope of the section and journal to which they are submitted, as defined in the mission statement. Frontiers reserves the right to direct out-of-scope manuscripts to a more appropriate section or journal at any stage of peer review.



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleI treat seriously ill people – and I urge politicians to vote against assisted dying legislation, which is of great concern. lucy thomas
Next Article Emergex T-cell priming vaccine candidate against betacoronavirus selected for inclusion in clinical trials by NIH/NIAID project NextGen
Paul E.
  • Website

Related Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

June 18, 2025

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

June 5, 2025

Better Choice Company announces SRX Health closure

April 25, 2025
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.